The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Urology


Psychiatry related information on Urology


High impact information on Urology

  • Classics in oncology. On the frequency of occurrence of occult carcinoma of the prostate: Arnold Rice Rich, M.D., Journal of Urology 33:3, 1935 [7].
  • Urology and the TNM classification [8].
  • BACKGROUND: Most studies that have described the sensitivity and specificity of prostate-specific antigen (PSA) as a screening test have been conducted in urology practice settings or in media-based screening programs [9].
  • CONCLUSIONS: The contributions of Victor Marshall to urology are notable in breadth and significance [10].
  • METHODS: 112 prostate samples from patients undergoing surgery at the Urology Clinic at the Zagreb Clinical Hospital Center from 1995 to 2003 were investigated in this study [11].

Chemical compound and disease context of Urology


Biological context of Urology


Anatomical context of Urology

  • METHODS: From 1989 to 2002, data were collected from 2264 patients complaining of lower urinary tract symptoms (LUTS) who visited the Department of Urology of the University Medical Centre Nijmegen, The Netherlands. Baseline PV and serum PSA was determined using standard techniques [22].
  • MATERIAL AND METHODS: Six patients who were seen in our general urology practice in Washington, D.C., with parenteral drug abuse involving the external genitalia were studied [23].
  • The aim of the study was to assess prostate cancer risk factors occurrence in the examined 193 men, aged 50-70 years, who reported to urology outpatient department at Clinical Hospital in Lublin, measure the PSA level in blood serum and examine the correlation between them [24].

Associations of Urology with chemical compounds

  • The holmium (Ho):YAG laser, which has cutting and coagulating properties, has been demonstrated to have many applications in urology [25].
  • CONCLUSIONS: Oxybutynin, a commonly used pharmacological agent in pediatric urology, was not associated with cognitive impairment following treatment [26].
  • With the introduction of the phosphodiesterase (PDE) 5 inhibitor sildenafil the concept of PDE inhibition has gained tremendous interest in the field of urology [27].
  • Clinical experience with ceftazidime in urology in Japan [28].
  • CONCLUSIONS: Gentamicin remains a valuable drug in urology [29].

Gene context of Urology

  • MRSA in Urology: A UK Hospital Experience [30].
  • Because the gamma-Sm (PSA) test seems likely to replace the PAP test in the area of urology and study of prostate-specific antigens is expanding, we have reviewed physicochemical properties and clinical significance of two prostate-specific antigens, gamma-Sm (PSA) and beta-microseminoprotein (beta-MSP) [31].
  • Routine serum PSA measurements in the population of patients consulting a urology department will no doubt bring about a new approach to the management of prostate cancer [32].
  • Since 1998 the Clinic of Urology in Kantonsspital Aarau has participated in the ERSPC (European Randomised Study of Screening for Prostate Cancer) study, which is designed to provide data on prostate cancer screening within a prospective randomised controlled setting [33].
  • Survey results on medical and surgical followup of patients with vesicoureteral reflux from American Association of Pediatrics, Section on Urology members [34].

Analytical, diagnostic and therapeutic context of Urology


  1. Platelet-type 12-lipoxygenase in a human prostate carcinoma stimulates angiogenesis and tumor growth. Nie, D., Hillman, G.G., Geddes, T., Tang, K., Pierson, C., Grignon, D.J., Honn, K.V. Cancer Res. (1998) [Pubmed]
  2. Succinylcholine-induced ventricular fibrillation in the paralyzed urology patient. Walker, D.E., Barry, J.M., Hdoges, C.V. J. Urol. (1975) [Pubmed]
  3. Renal cell carcinoma with extension into the inferior vena cava: problems in diagnosis, staging and treatment. Pagano, F., Dal Bianco, M., Artibani, W., Pappagallo, G., Prayer Galetti, T. Eur. Urol. (1992) [Pubmed]
  4. Corynebacterium group D2 pyelonephritis. Schoch, P.A., Ferragamo, M.A., Cunha, B.A. Urology (1987) [Pubmed]
  5. Smart drugs in prostate cancer. van der Poel, H.G. Eur. Urol. (2004) [Pubmed]
  6. Re: Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting. Subramonian, K., Weston, P.M. J. Urol. (1999) [Pubmed]
  7. Classics in oncology. On the frequency of occurrence of occult carcinoma of the prostate: Arnold Rice Rich, M.D., Journal of Urology 33:3, 1935. Rich, A.R. CA: a cancer journal for clinicians. (1979) [Pubmed]
  8. Urology and the TNM classification. Hermanek, P., Sobin, L.H. Lancet (1988) [Pubmed]
  9. Predictive properties of serum-prostate-specific antigen testing in a community-based setting. Jacobsen, S.J., Bergstralh, E.J., Guess, H.A., Katusic, S.K., Klee, G.G., Oesterling, J.E., Lieber, M.M. Arch. Intern. Med. (1996) [Pubmed]
  10. Victor Fray Marshall: twentieth century renaissance urologist. Boorjian, S., Vaughan, E.D., Pitts, W.R., Muecke, E.C. J. Urol. (2006) [Pubmed]
  11. Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue. Hudolin, T., Juretic, A., Spagnoli, G.C., Pasini, J., Bandic, D., Heberer, M., Kosicek, M., Cacic, M. Prostate (2006) [Pubmed]
  12. Controlled release of therapeutic agents: slow delivery and cell encapsulation. Machluf, M., Orsola, A., Atala, A. World journal of urology. (2000) [Pubmed]
  13. Follow up of urology patients discharged with urinary methicillin-resistant Staphylococcus aureus. Takahashi, S., Hirose, T., Takeyama, K., Satoh, T., Tsukamoto, T. J. Hosp. Infect. (1997) [Pubmed]
  14. Multicentricity in renal cell carcinoma. Bilen, C.Y., Mahalati, K., Ozen, H., Aki, F.T., Ilyas, C., Kendi, S. International urology and nephrology. (1999) [Pubmed]
  15. Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients. Johnson, J.R., Kuskowski, M.A., Wilt, T.J. Ann. Intern. Med. (2006) [Pubmed]
  16. EMP combination chemotherapy and low-dose monotherapy in advanced prostate cancer. Kitamura, T., Nishimatsu, H., Hamamoto, T., Tomita, K., Takeuchi, T., Ohta, N. Expert review of anticancer therapy. (2002) [Pubmed]
  17. This month in investigative urology. L-arginine and penile erection. Melman, A. J. Urol. (1997) [Pubmed]
  18. Vesicoureteral reflux: diagnosis and management. Badwan, K.H., Diamond, D.A. Le Journal médical libanais. The Lebanese medical journal. (2005) [Pubmed]
  19. Netilmicin kinetics in urology. Astobieta, A., Calvo, R., Aguirre, C., Rodríguez-Sasiain, J.M. International journal of clinical pharmacology, therapy, and toxicology. (1993) [Pubmed]
  20. Clinical characteristics of uremic pruritus in patients undergoing haemodialysis. Dar, N.R., Akhter, A. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. (2006) [Pubmed]
  21. Howard A. Kelly's development as an academician: some insights from his letters to Robert P. Harris. Longo, L.D. Transactions & studies of the College of Physicians of Philadelphia. (2002) [Pubmed]
  22. Prostate-specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasia. Mochtar, C.A., Kiemeney, L.A., van Riemsdijk, M.M., Barnett, G.S., Laguna, M.P., Debruyne, F.M., de la Rosette, J.J. Eur. Urol. (2003) [Pubmed]
  23. Sequelae of parenteral drug abuse involving the external genitalia. Mireku-Boateng, A.O., Nwokeji, C. Urologia internationalis. (2004) [Pubmed]
  24. Increasing level of prostate-specific antigen and prostate cancer risk factors among 193 men examined in screening procedure. Opalińska, E., Michalak, A., Stoma, F., Latalski, M., Goniewicz, M. Annales Universitatis Mariae Curie-Skłodowska. Sectio D: Medicina. (2003) [Pubmed]
  25. Holmium: YAG laser endoureterotomy for ureterointestinal strictures. Watterson, J.D., Sofer, M., Wollin, T.A., Nott, L., Denstedt, J.D. J. Urol. (2002) [Pubmed]
  26. The effect of oxybutynin treatment on cognition in children with diurnal incontinence. Sommer, B.R., O'Hara, R., Askari, N., Kraemer, H.C., Kennedy, W.A. J. Urol. (2005) [Pubmed]
  27. Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate. Uckert, S., Küthe, A., Jonas, U., Stief, C.G. J. Urol. (2001) [Pubmed]
  28. Clinical experience with ceftazidime in urology in Japan. Kawamura, N. J. Antimicrob. Chemother. (1983) [Pubmed]
  29. Gentamicin for the practicing urologist: review of efficacy, single daily dosing and "switch" therapy. Santucci, R.A., Krieger, J.N. J. Urol. (2000) [Pubmed]
  30. MRSA in Urology: A UK Hospital Experience. Thiruchelvam, N., Yeoh, S.L., Keoghane, S.R. Eur. Urol. (2006) [Pubmed]
  31. Two prostate-specific antigens, gamma-seminoprotein and beta-microseminoprotein. Hara, M., Kimura, H. J. Lab. Clin. Med. (1989) [Pubmed]
  32. The usefulness of prostate-specific antigen and prostatic acid phosphatase in clinical practice. Daver, A., Soret, J.Y., Coblentz, Y., Allain, Y.M., Cellier, P., Chauveau, P. Am. J. Clin. Oncol. (1988) [Pubmed]
  33. Prostate cancer screening: results of a prospective trial in Canton Aargau, Switzerland. Kwiatkowski, M., Huber, A., Moschopulos, M., Lehmann, K., Wernli, M., Häfeli, A., Recker, F. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology. (2004) [Pubmed]
  34. Survey results on medical and surgical followup of patients with vesicoureteral reflux from American Association of Pediatrics, Section on Urology members. Herndon, C.D., Ferrer, F.A., McKenna, P.H. J. Urol. (2001) [Pubmed]
  35. Evaluation of current practices in routine preoperative crossmatching for transurethral resection of the prostate. Robertson, G.S., Everitt, N.J., Burton, P., Flynn, J.T. J. Urol. (1993) [Pubmed]
  36. Correlation between 2 interstitial cystitis symptom instruments. Sirinian, E., Azevedo, K., Payne, C.K. J. Urol. (2005) [Pubmed]
  37. Effects of systematic 12-core biopsy on the performance of percent free prostate specific antigen for prostate cancer detection. Canto, E.I., Singh, H., Shariat, S.F., Kadmon, D., Miles, B.J., Wheeler, T.M., Slawin, K.M. J. Urol. (2004) [Pubmed]
  38. This month in investigative urology: adoptive immunotherapy of genitourinary tumors with interleukin-2. Linehan, W.M. J. Urol. (1988) [Pubmed]
  39. Intravesical instillation of capsaicin in urology: A review of the literature. de Sèze, M., Wiart, L., Ferrière, J., de Sèze, M.P., Joseph, P., Barat, M. Eur. Urol. (1999) [Pubmed]
WikiGenes - Universities